4NMM
Crystal Structure of a G12C Oncogenic Variant of Human KRas Bound to a Novel GDP Competitive Covalent Inhibitor
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 19-ID |
Synchrotron site | APS |
Beamline | 19-ID |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2013-06-12 |
Detector | ADSC QUANTUM 315 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 39.088, 42.022, 91.159 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 45.580 - 1.890 |
R-factor | 0.186 |
Rwork | 0.184 |
R-free | 0.23700 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4epv |
RMSD bond length | 0.015 |
RMSD bond angle | 1.364 |
Data reduction software | HKL-3000 |
Data scaling software | HKL-3000 |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0049) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 1.930 |
High resolution limit [Å] | 1.890 | 1.900 |
Rmerge | 0.126 | 0.883 |
Number of reflections | 12363 | |
<I/σ(I)> | 14.469 | 2.036 |
Completeness [%] | 99.8 | 100 |
Redundancy | 5.8 | 5.1 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 4 | 277 | 0.2M MMT pH4.0, 28% PEG 6,000, VAPOR DIFFUSION, HANGING DROP, temperature 277K |